Thinking of joining a study?

Register your interest

NCT06377982 | NOT YET RECRUITING | Cerebral Palsy

Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy

StemCyte Taiwan Co., Ltd.

Brief Summary:

A phase I, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of allogeneic human umbilical cord blood infusion in children with cerebral palsy

Condition or disease

Cerebral Palsy





Detailed Description:

This is a phase I study to evaluate the safety and efficacy in hUCB treatment on the patients with cerebral palsy (CP).

Estimated Enrollment : 12 participants
Masking : DOUBLE
Primary Purpose : TREATMENT
Official Title : A Phase I, Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Safety and Efficacy of Allogeneic Human Umbilical Cord Blood Infusion in Children With Cerebral Palsy
Actual Study Start Date : 2024-09
Estimated Primary Completion Date : 2026-09
Estimated Study Completion Date : 2026-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 1 Year to 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Inclusion Criteria
  • * Male or female underage at the time of screening.
  • * With a confirmed diagnosis of CP
  • * non-progressive motor disability
  • * brain dysfunction
Exclusion Criteria
  • * Judged by the Investigator to be not suitable/eligible for study participation.

Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy

Location Details


Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.


No Location Found